Showing 2221-2230 of 3553 results for "".
The Placebo and Nocebo Effects in Dermatology
https://practicaldermatology.com/columns/clinical-focus-1/the-placebo-and-nocebo-effects-in-dermatology/23559/Increasing evidence suggests that these effects—though not fully understood—may be harnessed for patient care.Galderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti for 195 million dFive Hot Things Patients Are Asking for This Winter
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/five-hot-things-patients-are-asking-for-this-winter/23849/New year, new treatment menu.Comorbidities in Alopecia Areata
https://practicaldermatology.com/issues/july-2025/comorbidities-in-alopecia-areata/36507/Alopecia areata (AA) is a chronic, relapsing immune-mediated disorder that causes nonscarring hair loss that can significantly impact a patient’s quality of life.Molluscum: Challenges and a Promising Solution
https://practicaldermatology.com/topics/rare-disease/molluscum-challenges-and-a-promising-solution/23532/Molluscum is under-diagnosed and under-treated in the US, but a new treatment could change that.Protect Your Practice from Fraud, Part 2
https://practicaldermatology.com/topics/practice-management/protect-your-practice-from-fraud-part-2/23606/Part 2 of this series reviews common in-office areas of your practice that may be susceptible to fraud and offers tips for protecting yourself and your practice.Rising Skin Cancer Rates are a Global Reality
https://practicaldermatology.com/topics/general-topics/PD1009_04-php/20367/One group of researchers questions the skin cancer epidemic, but the overwhelming evidence suggests that rates are rising.New Products
https://practicaldermatology.com/columns/new-products/new-products/20961/New Products
https://practicaldermatology.com/columns/new-products/new-products/20547/New Products and Pharmacologic DevelopmentsNext Generation Retinoids
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/next-generation-retinoids/23599/The search for a more tolerable retinoid has led to study of unique delivery systems, novel retinoid molecules, and even botanicals.